EXSCIENTIA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5 USD | +7.07% |
|
+8.23% | -22.00% |
| Mar. 21 | Exscientia Files $300 Million Mixed Shelf | MT |
| Mar. 21 | Transcript : Exscientia plc, 2023 Earnings Call, Mar 21, 2024 |
Presenter SpeechMichael Ryskin (Analysts)I think in the interest of time, we're going to kick ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Exscientia PLC is a United Kingdom-based artificial intelligence (AI)-driven precision medicine company. It is focused on discovering, designing and developing the possible drugs. It has developed the functional precision oncology platform to guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Its internal pipeline is focused on leveraging its precision medicine platform in oncology, while its partnered pipeline broadens its approach to other therapeutic areas. Its patient-first AI platform includes Precision Target, Precision Design, Precision Experiment, Precision Medicine, Presentations and Publications. Its Precision Target combines genetic data and global literature in machine learning models to anticipate and confirm disease-target associations. Its advanced biophysical and x-ray techniques provide the ideal experimental underpinnings for AI-design.
Calendar
2024-05-21
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
3.977
GBP
Average target price
6.873
GBP
Spread / Average Target
+72.81%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -22.00% | 632M | |
| +22.81% | 46.81B | |
| +47.02% | 41.29B | |
| -1.88% | 41.37B | |
| -6.20% | 28.87B | |
| +11.33% | 26.06B | |
| -21.00% | 19.13B | |
| -1.43% | 11.96B | |
| +30.73% | 12.39B | |
| -0.48% | 12.08B |
- Stock Market
- Equities
- EXAI Stock
- News Exscientia plc
- Transcript : Exscientia plc Presents at Bank of America 2022 Healthcare Conference, May-10-2022 05